These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35781165)

  • 21. Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study.
    Feng N; Ezechi O; Uwandu M; Abimbola BS; Vincent GD; Idigbe I; Okoli LC; Adesina M; Okwuzu J; Ahmed RA; Sokei J; Shaibu JO; Momoh AE; Sowunmi O; Labo-Popoola OH; ; Ohihoin G; David A; Nzeribe E; Olaleye O; Dong XP; Onwuamah CK
    BMC Public Health; 2022 Oct; 22(1):1922. PubMed ID: 36243709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.
    Johnson DC; Bhatta MP; Smith JS; Kempf MC; Broker TR; Vermund SH; Chamot E; Aryal S; Lhaki P; Shrestha S
    PLoS One; 2014; 9(6):e101255. PubMed ID: 24978811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Bergengren L; Kaliff M; Larsson GL; Karlsson MG; Helenius G
    Int J Gynaecol Obstet; 2018 Sep; 142(3):359-364. PubMed ID: 29856071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening.
    Arbyn M; Castle PE; Schiffman M; Wentzensen N; Heckman-Stoddard B; Sahasrabuddhe VV
    Int J Cancer; 2022 Jul; 151(2):308-312. PubMed ID: 35179777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia.
    Kaoma M; Olayemi O; Mwaba MH; Sikwewa K
    BMC Womens Health; 2023 Feb; 23(1):62. PubMed ID: 36774526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
    Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
    J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Kim MH; Jung HJ; Park SI; Kim BJ
    Int J Gynaecol Obstet; 2021 Jul; 154(1):127-132. PubMed ID: 33368281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.
    Nelson EJ; Maynard BR; Loux T; Fatla J; Gordon R; Arnold LD
    Sex Transm Infect; 2017 Feb; 93(1):56-61. PubMed ID: 28100761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System.
    Ilardo C; Marguerettaz M; Breton A; Azzoug T; Schmitt N; Fournier R; Bayette J; Teissier G; Lelarge C; Ponseille B
    New Microbiol; 2022 Apr; 45(2):111-114. PubMed ID: 35699559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 38. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
    Di Gennaro G; Licata F; Trovato A; Bianco A
    Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test.
    Tranberg M; Jensen JS; Bech BH; Blaakær J; Svanholm H; Andersen B
    BMC Infect Dis; 2018 Jul; 18(1):348. PubMed ID: 30053836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.